low molecular weight heparins

low molecular weight heparins

Heparins that can be isolated from standard heparin by differential precipitation with ethyl alcohol or by gel filtration chromatography or other means. These heparins differ in their mode of action and pharmacological and immunological properties from normal heparin and are useful in cases in which side effects such as heparin-induced THROMBOCYTOPENIA have occurred. They have advantages over heparin in the treatment of venous thrombosis. They bind much less avidly to heparin-binding proteins than does heparin. This increases their bioavailability at low doses and makes their anticoagulant response more predictable. The group includes certoparin (Alphaparin), dalteparin sodium (Fragmin), enoxaparin (Clexane), reviparin sodium (Clivarine) and tinzaparin (Innohep).
References in periodicals archive ?
Compare and contrast the pharmacokinetics of different low molecular weight heparins (LMWH)
M2 PHARMA-September 13, 2010-Momenta wins US patent for evaluating mixtures of low molecular weight heparins by chain mapping(C)2010 M2 COMMUNICATIONS
Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
Low molecular weight heparins have been used to reduce thromboembolic risk in both primary care and the hospital setting for at least twenty years (Clagett et al 1995, Imberti et al 2006, Mohr et al 1993, Wolf 1994).
The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery.
Low molecular weight heparins (LMWH) have been shown to be effective and safe for the treatment of deep venous thrombosis and pulmonary embolism.
This test may not be performed by all labs, but may be available at labs with a blood bank or those currently testing anti-Xa levels for other low molecular weight heparins.
Low molecular weight heparins contain that sequence, so their binding is specific to antithrombin and they are less susceptible to interfering substances such as endothelium, platelets, platelet factor IV, and plasma proteins.
Nurses will be administering low molecular weight heparins for more arterial and venous thrombotic conditions in the future.
com/research/s47trc/heparin_sodium) has announced the addition of the "Heparin sodium (CAS 9041-08-1), Low Molecular Weight Heparins Market Research Report 2012" report to their offering.
Object of the contract includes the delivery of the following groups of drugs, which are separate tasks (parts of) the contract Task 1 infusion fluidsTask 2 Psychotropic drugsTask 3 DrugsTask 4 different drugsTask 5 medicines in hospital packsTask 6 AntibioticsTask 7 Liquids infusion in packs of specialist and parenteral nutritionTask 8-inflammatory drugsTask 9 low molecular weight heparinsTask 10 low molecular weight heparins - EnoxaparinTask 11 low molecular weight heparins - DalteparinA detailed list of inventory ordered drugs and their estimated amounts set out in the tables contained in Part II of the Terms of Reference.

Full browser ?